Skip to main content
logo
Rani Therapeutics Holdings, Inc. (RANI)
NASDAQ: RANI · Real-Time Price · USD
0.9600
+0.0761 (8.61%)
May 6, 2026, 12:46 PM EDT - Market open

RANI Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
May '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Cap
961644686149322
Market Cap Growth
161.86%259.69%-47.20%-42.08%-53.69%-
Enterprise Value
42.83125.6732.7574.96117.12278.99
Last Close Price
0.961.351.373.325.9016.35
PE Ratio
--3.00-1.30-2.50-4.61-38.02
PS Ratio
54.03100.5244.39--118.62
PB Ratio
2.614.9722.916.724.056.80
P/TBV Ratio
1.922.7119.586.583.816.74
P/FCF Ratio
--8.73-1.28-1.65-3.10-9.84
P/OCF Ratio
--8.77-1.29-1.69-3.21-10.00
EV/Sales Ratio
26.2376.9631.86--102.69
EV/EBITDA Ratio
--3.36-0.63-1.15-1.86-5.46
EV/EBIT Ratio
--3.28-0.61-1.13-1.85-5.41
EV/FCF Ratio
--6.68-0.92-1.43-2.43-8.52
Debt / Equity Ratio
0.070.073.790.960.390
Debt / EBITDA Ratio
-0.11-0.11-0.57-0.46-0.48-
Debt / FCF Ratio
-0.23-0.23-0.83-0.57-0.63-
Net Debt / Equity Ratio
-1.37-1.371.04-1.43-1.85-2.48
Net Debt / EBITDA Ratio
1.211.21-0.040.281.092.30
Net Debt / FCF Ratio
2.412.41-0.060.351.423.59
Asset Turnover
0.030.030.02000.03
Quick Ratio
4.084.081.416.0820.4544.49
Current Ratio
4.214.211.506.3620.9645.30
Return on Equity (ROE)
-181.98%-181.98%-391.10%-136.52%-64.78%-1290.42%
Return on Assets (ROA)
-80.44%-80.44%-112.77%-79.66%-54.58%-50.64%
Return on Invested Capital (ROIC)
-749.49%-749.49%-848.54%-1037.74%-1286.92%-1116.12%
Return on Capital Employed (ROCE)
-122.21%-122.21%-159.93%-86.33%-56.46%-52.74%
Earnings Yield
-33.63%-33.33%-76.64%-40.06%-21.69%-2.63%
FCF Yield
-21.31%-11.45%-78.37%-60.70%-32.25%-10.16%
Buyback Yield / Dilution
-132.26%-132.26%-11.65%-7.09%-21.93%58.34%
Total Shareholder Return
-132.26%-132.26%-11.65%-7.09%-21.93%58.34%
Updated Mar 26, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q